Mucus-Targeting inhaler tested for lung disease – study stopped early
NCT ID NCT05292950
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This study tested an inhaled drug called ARO-MUC5AC in healthy people and those with asthma or COPD. The goal was to see if it was safe and could improve lung function by reducing mucus. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site 1
Nedlands, 6009, Australia
-
Research Site 1
Auckland, 1010, New Zealand
-
Research Site 1
Bialystok, 15-010, Poland
-
Research Site 1
Seoul, 04763, South Korea
-
Research Site 1
Barcelona, 08017, Spain
-
Research Site 1
Bangkok, 10700, Thailand
-
Research Site 1
Wythenshawe, Manchester, M23 9QZ, United Kingdom
-
Research Site 2
South Brisbane, Queensland, 4101, Australia
-
Research Site 2
Auckland, 1051, New Zealand
-
Research Site 2
Krakow, 31-455, Poland
-
Research Site 2
Jeonju, 54907, South Korea
-
Research Site 3
Oświęcim, 32-600, Poland
-
Research Site 3
Bucheon-si, Gyeonggi-do, 14647, South Korea
Conditions
Explore the condition pages connected to this study.